Impact of SGLT inhibitors on multiple organ defects in diabetes.

CONCLUSION: The use of SGLT inhibitor in the treatment of type 2 diabetes should be considered with the perspective of general health state of the patient. In fact, SGLT inhibitors promote pleiotropic effects, among which some are beneficial for certain organs while some are deleterious. PMID: 31702506 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31702506?dopt=Abstract

Source: Current Diabetes Reviews - November 4, 2019 Category: Endocrinology Authors: Asrih M, Gariani K Tags: Curr Diabetes Rev Source Type: research